{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:40:38Z","timestamp":1790991638154,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.jneuroim.2007.07.008","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T07:14:41Z","timestamp":1188544481000},"page":"127-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Genetic polymorphisms of macrophage-mediators in Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"190","author":[{"given":"Karin","family":"Geleijns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Emonts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Laman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"van Rijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.M.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2007.07.008_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(05)67424-7","article-title":"Genetic association studies","volume":"366","author":"Cordell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2007.07.008_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00075-6","article-title":"Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain\u2013Barr\u00e9 syndrome","volume":"68","author":"Creange","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.53.8.1683","article-title":"Matrix metalloproteinase-9 is increased and correlates with severity in Guillain\u2013Barr\u00e9 syndrome","volume":"53","author":"Creange","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.07.008_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp.2004.046227","article-title":"Amantadine for treatment of fatigue in Guillain\u2013Barr\u00e9 syndrome: a randomised, double blind, placebo controlled, crossover trial","volume":"77","author":"Garssen","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2007.07.008_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2004.01.003","article-title":"Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain\u2013Barr\u00e9 patients","volume":"150","author":"Geleijns","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib6","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.4049\/jimmunol.177.6.4211","article-title":"Mannose-binding lectin contributes to the severity of Guillain\u2013Barr\u00e9 syndrome","volume":"177","author":"Geleijns","year":"2006","journal-title":"J. Immunol."},{"issue":"Pt 3","key":"10.1016\/j.jneuroim.2007.07.008_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain\u2013Barr\u00e9 syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases","volume":"118","author":"Griffin","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2007.07.008_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410440517","article-title":"Genetic contribution of the tumor necrosis factor region in Guillain\u2013Barr\u00e9 syndrome","volume":"44","author":"Ma","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(03)00133-4","article-title":"Interleukin-10 promoter polymorphisms in patients with Guillain\u2013Barr\u00e9 syndrome","volume":"139","author":"Myhr","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.410330606","article-title":"Elevated serum levels of tumor necrosis factor-alpha in Guillain\u2013Barr\u00e9 syndrome","volume":"33","author":"Sharief","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.410420112","article-title":"Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain\u2013Barr\u00e9 syndrome","volume":"42","author":"Sharief","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/01.WNL.0000033799.58866.7A","article-title":"MMP-9 correlates with electrophysiologic abnormalities in Guillain\u2013Barr\u00e9 syndrome","volume":"59","author":"Sharshar","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.07.008_bib14","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1128\/MCB.20.24.9113-9119.2000","article-title":"Functional consequences of a polymorphism affecting NF-kappaB p50\u2013p50 binding to the TNF promoter region","volume":"20","author":"Udalova","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","article-title":"Mild forms of Guillain\u2013Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands","volume":"54","author":"van Koningsveld","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.07.008_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.01.016","article-title":"Severity of Guillain\u2013Barr\u00e9 syndrome is associated with Fc gamma Receptor III polymorphisms","volume":"162","author":"van Sorge","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.07.008_bib17","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.99.14.1788","article-title":"Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis","volume":"99","author":"Zhang","year":"1999","journal-title":"Circulation"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807002500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807002500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:07:19Z","timestamp":1759046839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572807002500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":17,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0165572807002500"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.07.008","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic polymorphisms of macrophage-mediators in Guillain\u2013Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}